Use of platelet-rich plasma for treatment of symptomatic degenerative lumbar disease
Lumbar intradiskal platelet-rich plasma (PRP) injections: a prospective, double-blind, randomized controlled studyPM R. 2016 Jan;8(1):1-10
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
58 patients with low back pain due to degenerative lumbar disease were randomized to intradiscal injection of 1-2mL of either platelet-rich plasma (PRP) or contrast agent (Omnipaque 180). The purpose of this study was to evaluate the efficacy of PRP for improvement of measures of pain and function relative to a nonactive injection. Follow-up was performed over 8 weeks post-injection. Results after...
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.Continue